Labshake search
Citations for R&D Systems :
401 - 450 of 2945 citations for 7 Bromo 2 Methyl 1 Indanone since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2021Quote: ... Recombinant human IL-2 protein was purchased from R&D Systems (Minneapolis, MN). Recombinant mouse Flt3 ligand (Flt3L ...
-
bioRxiv - Microbiology 2021Quote: ... supplemented with 20 IU/mL rhIL-2 (R&D Systems Cat# 202-IL) for 72±4 hours at 37°C and 5% CO2 ...
-
bioRxiv - Microbiology 2021Quote: ... Recombinant human IL-2 protein was purchased from R&D Systems (Minneapolis, MN). Recombinant mouse Flt3 ligand (Flt3L ...
-
bioRxiv - Bioengineering 2020Quote: ... 300 μl of reagent diluent (Reagent diluent concentrate 2, DY995, R&D systems) was added and incubated for an hour to block the coated plate ...
-
bioRxiv - Microbiology 2021Quote: ... and cultured in media containing IL-2 (5 ng/ml; R&D Systems), in the presence or in the absence of GGSK2691805A (5 μM) ...
-
bioRxiv - Microbiology 2020Quote: ... and 2 ng/ml recombinant mouse TGF-β (R&D Systems, Minneapolis, MN).
-
bioRxiv - Immunology 2020Quote: ... and an Equine IL-2 DuoSet ELISA (R&D Systems, Minneapolis, MN, USA). Measurements were performed in duplicate according to the manufacturer’s protocol.
-
bioRxiv - Immunology 2020Quote: ... anti-human IL-37 (2 μg/ml, goat polyclonal, R&D Systems, AF1975), anti-human caspase-1 p20 (1:1000 ...
-
bioRxiv - Immunology 2022Quote: ... alone or with mouse recombinant IL-2 (R&D Systems, 50 ng/ml) for 15 minutes at 37°C ...
-
bioRxiv - Neuroscience 2023Quote: ... supplemented with 20 ng/mL FGF-2 (R&D Systems, 233-FB-010), and 20 ng/mL PDGF-AA (R&D Systems ...
-
bioRxiv - Microbiology 2022Quote: ... AF488 anti-SARS-CoV-2 Spike S1 Subunit (R&D Systems,Cat# FAB105403G), FITC anti-Influenza A NP (Thermofisher ...
-
bioRxiv - Microbiology 2023Quote: ... were coated with 100 µl rSARS-CoV-2 spike protein (R&D Systems). To detect total IgA+-expressing B cells ...
-
bioRxiv - Cancer Biology 2022Quote: ... and recombinant human IL-2 20 ng/ml (202-IL, R&D Systems). The QCM Leukocyte Migration Assay (MilliporeSigma ...
-
bioRxiv - Immunology 2023Quote: ... probed with anti-mouse Ms-RD-SARS-COV-2 (R&D Systems, MAB105401) followed by HRP secondary antibody provided in Jess kits (Protein Simple ...
-
bioRxiv - Immunology 2023Quote: ... and the Mouse/Rat Angiopoietin-2 Quantikine ELISA Kit (MANG20, R&D Systems), respectively ...
-
bioRxiv - Immunology 2023Quote: Recombinant Human IL-2 and human TGF-β were from R&D systems. Anti-mouse CD3 and biotin-anti-CD3 (145-2C11 ...
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/mL of IL-2 (R&D systems, 404-ML-010)) ...
-
bioRxiv - Microbiology 2023Quote: ... 2) 50 nM recombinant USP2 catalytic domain (R&D systems, Cat# E-504), 3 ...
-
bioRxiv - Immunology 2024Quote: ... Intraperitoneal injections of 2.5μg/0.02kg rhIL-15 (R&D systems; Supplemental Table 2) were performed for 3 weeks to increase reconstitution and maturation of human NK cells in hBLT mice ...
-
bioRxiv - Bioengineering 2024Quote: ... and 10 ng/ml fibroblast growth factor-2 (R&D Systems, Minneapolis, MN). For pellet cultures ...
-
bioRxiv - Bioengineering 2022Quote: ... angiopoietin-1 (ANG-1, R&D Systems) and hepatocyte growth factor (HGF ...
-
bioRxiv - Cell Biology 2022Quote: ... NKX6-1 (1:1000; R&D Systems), NR4A2 (NURR1 ...
-
bioRxiv - Cell Biology 2022Quote: ... NED] and 3U.ml−1 EPO [Roche]) supplemented with 1 ng.ml−1 IL→ 3 and 10 ng.ml−1 SCF (both R&D Systems) and 1 µg.ml−1 doxycycline for 4 days ...
-
bioRxiv - Cell Biology 2020Quote: ... during 2 hours and stimulated with human recombinant VEGF165 (25ng/ml, R&D System) during 30 minutes.
-
bioRxiv - Immunology 2021Quote: ... and DuoSet Human IFN-gamma kit and Ancillary Reagent Kit 2 (R&D Systems) were performed according to manufacturer’s instructions ...
-
bioRxiv - Immunology 2019Quote: ... NK cells were activated for 72h in 300IU/ml rhIL-2 (R&D Systems). CD4 T cells were simultaneously activated and infected as described above ...
-
bioRxiv - Bioengineering 2019Quote: ... 0.004 % of recombinant human FGF basic (FGF-2, R&D Systems, Abingdon, United Kingdom) was added ...
-
bioRxiv - Bioengineering 2020Quote: ... and recombinant human IL-2 (50 U/mL, R&D Systems, Minneapolis, MN, USA). Single cell suspensions were activated with 1 μg/ml Concavalin A (Sigma ...
-
bioRxiv - Cell Biology 2021Quote: ... 0.1% 2-Mercaptoethanol and 10 ng/mL basic FGF (R&D Systems, 233-FB). For MyoD+F/R/C condition ...
-
bioRxiv - Bioengineering 2021Quote: ... 100M PBMCs were thawed in 100 mL X-VIVO™ 10 media from Lonza (#04-380Q) with recombinant human IL-2 protein from R&D Systems (#202-IL). After a 24 hr culture out of thaw the PBMCs were activated with ImmunoCult™ human CD3/CD28 T cell activator reagent from STEMCELL Technologies (#10971 ...
-
bioRxiv - Pharmacology and Toxicology 2022Quote: ... and Mouse/Rat/Canine/Porcine TGF-beta 2 Quantikine ELISA Kit (R&D Systems). For the TGFβ2 assay ...
-
bioRxiv - Immunology 2022Quote: ... supplemented with 30 U/mL recombinant human IL-2 (R&D Systems #202-IL), and 55 μM beta- mercaptoethanol (Thermo # 21985023) ...
-
bioRxiv - Developmental Biology 2019Quote: ... After 2 days EBs were treated with 100 ng/ml Noggin (R&D Systems) and 10 mM SB431542 (Tocris ...
-
bioRxiv - Immunology 2019Quote: ... IL-1β (PBMC: 2 ng/ml, whole blood: 20 ng/ml, R&D Systems), (5 ...
-
bioRxiv - Immunology 2019Quote: ... overnight before addition of 500 IU/ml recombinant human IL-2 (R&D Systems).
-
bioRxiv - Immunology 2019Quote: ... MN) in combination with hrIFNβ at 2 ng/ml (R&D Systems, Minneapolis, MN) or when indicated hrISG15 at 0.115 μg/ml (Biotechne ...
-
bioRxiv - Biochemistry 2020Quote: ... Recombinant human MMP-2 (902-MP-010) was purchased from R&D systems (USA). Recombinant human MMP-3 (SRP7783 ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... and Mouse/Rat/Canine/Porcine TGF-beta 2 Quantikine ELISA Kit (R&D Systems). For the TGFβ2 assay ...
-
bioRxiv - Pathology 2021Quote: ... Samples were assayed into a Human ACE-2 DuoSet ELISA assay (R&D systems), loading equal amounts of protein in duplicate for all samples.
-
bioRxiv - Immunology 2021Quote: ... Recombinant SARS-CoV-2 Spike glycoprotein was purchased from R&D Systems (Minneapolis, MN). Bovine serum albumin (BSA ...
-
bioRxiv - Immunology 2022Quote: ... SARS-CoV-2 B.1.1.529 S GCN4-IZ-2P (11061-CV, R&D Systems), MERS-CoV S GCN4-IZ-2P (R&D Systems) ...
-
bioRxiv - Bioengineering 2022Quote: ... or 150 ng/ml recombinant human LOX homolog like 2 (LOXL2, R&D Systems), with media changed every 2-3 days ...
-
bioRxiv - Immunology 2022Quote: ... 200 IU/ml of recombinant human IL-2 (R&D Systems, 202-IL-050) and expanded for 10 – 14 days ...
-
bioRxiv - Neuroscience 2022Quote: ... and 100 ng/mL OX-2 membrane glycoprotein (CD200) (R&D systems, cat.no. 27712CD050) growth factors in addition to the previously described growth factors.
-
bioRxiv - Neuroscience 2023Quote: ... Media was supplemented with 2% fetal bovine serum (FBS) (R&D Systems, Minneapolis, MN), 1% penicillin-streptomycin 10,000U/mL (Gibco) ...
-
bioRxiv - Cell Biology 2023Quote: ... we used the Mouse IL-2 DuoSet ELISA kit (R&D Systems; DY402-05) following the manufacturer’s protocol ...
-
bioRxiv - Immunology 2023Quote: ... supplemented with 20 ng/mL of recombinant mouse interleukin (IL)- 2 (R&D systems), 8% CTS Immune Cell Serum Replacement (Thermo Fisher) ...
-
Low-dose cytokine immunotherapy of solid cancers enabled by phagocytic-competent protein co-crystalsbioRxiv - Cancer Biology 2023Quote: ... 3 and 6 days and subsequently tested by IL-2 ELISA (R&D Systems) according to the manufacturer’s protocol.
-
bioRxiv - Cancer Biology 2023Quote: ... purified sheep IgG (2 mg/mL for LRIG1 R&D Systems #5-001-A), and mouse IgG1-PE conjugate (10 uL for LGR5 ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 μM Y-27632 and 2 ng/mL human recombinant BMP4 (R&D Systems) and then cultured in ultra-low attachment 6 well plate (Corning ...